Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Cash from Investing Activities (2016 - 2025)

Utah Medical Products has reported Cash from Investing Activities over the past 16 years, most recently at -$109000.0 for Q4 2025.

  • Quarterly results put Cash from Investing Activities at -$109000.0 for Q4 2025, down 1111.11% from a year ago — trailing twelve months through Dec 2025 was -$371000.0 (down 78.37% YoY), and the annual figure for FY2025 was -$371000.0, down 78.37%.
  • Cash from Investing Activities for Q4 2025 was -$109000.0 at Utah Medical Products, down from -$27000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for UTMD hit a ceiling of $5000.0 in Q1 2024 and a floor of -$321000.0 in Q3 2022.
  • Median Cash from Investing Activities over the past 5 years was -$99500.0 (2023), compared with a mean of -$129400.0.
  • Biggest five-year swings in Cash from Investing Activities: soared 111.63% in 2024 and later tumbled 3780.0% in 2025.
  • Utah Medical Products' Cash from Investing Activities stood at -$253000.0 in 2021, then skyrocketed by 84.98% to -$38000.0 in 2022, then crashed by 136.84% to -$90000.0 in 2023, then soared by 90.0% to -$9000.0 in 2024, then tumbled by 1111.11% to -$109000.0 in 2025.
  • The last three reported values for Cash from Investing Activities were -$109000.0 (Q4 2025), -$27000.0 (Q3 2025), and -$51000.0 (Q2 2025) per Business Quant data.